lopinavir/ritonavir mylan
mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.
zybera 250 mg tablet
teva pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains abiraterone 250,0 mg
moxifloxacin 400/250 mg/ml solution for infusion
fresenius kabi limited - moxifloxacin hci, anhydrous - solution for infusion - 400/250 mg/ml - fluoroquinolones
moxifloxacin 400/250 mg/ml solution for infusion
fresenius kabi limited - moxifloxacin hci, anhydrous - solution for infusion - 400/250 mg/ml - fluoroquinolones
moxifloxacin 400 mg/250 ml solution for infusion, kabipac bottles
fresenius kabi deutschland gmbh - moxifloxacin - solution for infusion - 400/250 milligram(s)/millilitre - fluoroquinolones; moxifloxacin
moxifloxacin 400 mg/250 ml solution for infusion, freeflex bags
fresenius kabi deutschland gmbh - moxifloxacin - solution for infusion - 400/250 milligram(s)/millilitre - fluoroquinolones; moxifloxacin
moxifloxacin stada 400 mg filmtabletten